DASH prediction score
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: (insert your name here)
Synonyms and keywords: (add synonyms and create redirects)
Overview
[Name of the Score] is a (± validated) risk assessment tool designed to assess the (30-day/10-year/other timeframe) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).
DASH Prediction Score
- DASH Prediction Score was invented by A. Tosetto et al in 2012[1], and has been externally validated in subsequent study in 2017[2] particularly in young adults.
- DASH Prediction Score is a clinical prediction rule devised to assess the recurrence in patients with previous unprovoked venous thromboembolism especially in people aged <65 years.This helps decide whether anticoagulation be continued indefinitely or stopped after at least 3 months of anticoagulation.[3]
DASH Prediction Score Calculator
Shown below is the calculator for DASH prediction score (check all the boxes that apply):
Interpretation
| Score | Annualized recurrence
rate (%) |
Cumulative recurrence rate(%) | ||
|---|---|---|---|---|
| 1 year | 2 year | 5 year | ||
| - 2 | 1.8 | 2.4 | 5.2 | 5.2 |
| - 1 | 1.0 | 1.9 | 1.9 | 5.7 |
| 0 | 2.4 | 4.2 | 5.4 | 9.5 |
| 1 | 3.9 | 5.1 | 8.7 | 15.9 |
| 2 | 6.3 | 8.4 | 12.8 | 25.3 |
| 3 | 10.8 | 14.6 | 20.5 | 40.9 |
| 4 | 19.9 | 21.9 | 33.6 | 61.3 |
- Score – 2: annualized recurrence rate 1.8%
- Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
- Score ≥ 4: high-risk (> 5% mortality); treatment/hospitalization is warranted.
See also
- (Relevant score 1)
- (Relevant score 2)
- (Relevant score 3)
References
- ↑ Tosetto, A.; Iorio, A.; Marcucci, M.; Baglin, T.; Cushman, M.; Eichinger, S.; Palareti, G.; Poli, D.; Tait, R. C.; Douketis, J. (2012). "Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)". Journal of Thrombosis and Haemostasis. 10 (6): 1019–1025. doi:10.1111/j.1538-7836.2012.04735.x. ISSN 1538-7933.
- ↑ Tosetto, A.; Testa, S.; Martinelli, I.; Poli, D.; Cosmi, B.; Lodigiani, C.; Ageno, W.; De Stefano, V.; Falanga, A.; Nichele, I.; Paoletti, O.; Bucciarelli, P.; Antonucci, E.; Legnani, C.; Banfi, E.; Dentali, F.; Bartolomei, F.; Barcella, L.; Palareti, G. (2017). "External validation of the DASH prediction rule: a retrospective cohort study". Journal of Thrombosis and Haemostasis. 15 (10): 1963–1970. doi:10.1111/jth.13781. ISSN 1538-7933.
- ↑ Fahrni J, Husmann M, Gretener SB, Keo HH (2015). "Assessing the risk of recurrent venous thromboembolism--a practical approach". Vasc Health Risk Manag. 11: 451–9. doi:10.2147/VHRM.S83718. PMID 26316770.